MyoKardia Competitors, Revenue, Alternatives and Pricing

Claim your profile

Overview

Location:
Total Funding:$114.4M
Industry:Biotech
Founded:2012
Lead Investor(s):J.P. Morgan Securities LLC, Cowen and Company, LLC

Industry Ranking

Growjo 10k Ranking

Estimated Revenue & Financials

  • MyoKardia's estimated annual revenue is currently $33.6M per year.
  • MyoKardia received $Undisclosed in venture funding in August 2017.
  • MyoKardia's estimated revenue per employee is $102,939
  • MyoKardia's total funding is $114.4M.

Employee Data

  • MyoKardia has 326 Employees.
  • MyoKardia grew their employee count by 33% last year.
  • MyoKardia currently has 1 job openings.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingOnline ReviewPricing
DiaCarta
$7M4510%N/A-N/A
Geron Corporati...
N/A205N/AN/A-N/A
Rigel Pharmaceu...
$46.8M3024%N/A-N/A
Althea Technolo...
$22.3M144N/AN/A-N/A
INOVA Diagnosti...
$44.3M286N/AN/A-N/A
10X Genomics
$101.2M65346%N/A-N/A
ProTrials Resea...
$33.3M2153%N/A-N/A
Advanced Cell D...
$28.7M1858%N/A-N/A
The J. Craig Ve...
$39.4M254N/AN/A-N/A
CellMax Life
$6.5M4214%N/A-N/A
Missing a competitor? Contribute!?
Submit

Our Mission: Change the world for patients with cardiovascular disease through bold and innovative science. MyoKardia is a clinical stage biopharmaceutical company pioneering a precision medicine approach to discover, develop and commercialize targeted therapies for the treatment of serious and neglected rare cardiovascular diseases. Our initial focus: treatment of heritable cardiomyopathies, a group of genetically-driven forms of heart failure that result from biomechanical defects in cardiac muscle contraction. We are a growing community of employees who enjoy working with and learning from each other. We collaborate in a way that ensures the growth of the company as well each employee individually. MyoKardia is committed to creating a culture that's centered on our core values. We seek individuals who not only offer expertise in their respective fields, but can serve as cultural leaders and role models for our values. Apply: http://myokardia.com/careersOpp.php Learn More: http://myokardia.com/

keywords:Biotechnology,Healthcare,Pharmaceuticals

326

Number of Employees

$33.6M

Revenue (est)

1

Current Jobs

33%

Employee Growth %

$114.4M

Total Funding

N/A

Valuation

N/A

Accelerator

B2B

Type

MyoKardia News

26-Aug-19 - MyoKardia Announces Abstracts Selected for Presentation at ...

SOUTH SAN FRANCISCO, Calif., Aug. 26, 2019 (GLOBE NEWSWIRE) -- MyoKardia, Inc. (Nasdaq: MYOK) today announced the presentation ...

11-Sep-19 - MyoKardia to Evaluate Mavacamten as an Alternative to ...

MyoKardia to Evaluate Mavacamten as an Alternative to Septal Reduction Therapy in Obstructive Hypertrophic Cardiomyopathy Patients.

31-Aug-19 - MyoKardia Presents 36-week Data from PIONEER-OLE Study ...

Durability of Mavacamten's Safety and Efficacy Profile Demonstrated through Nine Months in this Study of Patients with Symptomatic, ...

MyoKardia Funding

DateAmountRoundLead InvestorsReference
2012-09-21$38.0MAArticle
2015-05-01$46.0MBArticle
2017-08-09$UndisclosedUndisclosedJ.P. Morgan Securities LLCArticle

MyoKardia Executive Hires

DateNameTitleReference
2013-01-31Jonathan FoxChief Medical OfficerArticle
2013-10-31Tassos GianakakosChief Executive OfficerArticle
2017-02-02June LeeCOOArticle
2018-01-22Cynthia LaddGeneral CounselArticle
2019-01-24William FaireyEVP/Chief Commercial OfficerArticle